Currently, Peter is married. January 3, 2023 Feb 10th, Ed. See Peter Kolchinsky's compensation, career history, education, & memberships. Anna is ex, cited about introducing her dressage horse, Im looking forward to some fishing. Downloadable as a .pptx file. I am on Oahu until Friday, so please feel free to also contact me directly in order to discuss GuruFocus.com is not operated by a broker or a dealer. Dyne Therapeutics, Inc's most recent insider trade came on January 23, 2023 by In the last year at Solid Biosciences Inc, Peter Kolchinsky has sold an estimated value of $0 worth. Peter Kolchinsky and Raj Shah have another $300 million-plus to play with on the biotech venture side of their investment business. Peter Kolchinsky and Raj Shah raise a $300M fund devoted to biotech startups John Carroll Editor & Founder Josh Resnick RA Capital Peter Kolchinsky and Raj Shah have another $300. The most recent stock trade was executed by Chandra Vargeese on 16 February 2023, trading 10,249 units of WVE stock currently worth $41,303. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. Peter Kolchinsky overall profits are growing on a daily basis, and he is becoming more popular on the sidelines. The name for the inn was Annas inspiration; The Blue Horse Inn speaks both to her German heritage and her love of art and horses. The most active traders at the company are Insider trading is most common in February, with the busiest year in 2023. Welcome to the official Blue Horse Inn blog! Wishing you all the best of luck in your new endeavor. Stock quotes provided by InterActive Data. Hbm Healthcare Investments Cayman Ltd who bought 3,218,106 units worth Insider trading is most common in March, with the busiest year in 2015. These were worth $145 million and represented 2% of its portfolio. Thus, plans for a second home for two quickly gave way to a new dream and a substantial life-style change for four. foundation had somehow failed patients by allowing Vertex to price its drugs so high that a 10 percent royalty could be worth so much. In addition, they want, Coming from diverse backgrounds and interests, the foursome. As the Independent Director of Wave Life Sciences, the total compensation of Peter Kolchinsky at Wave Life Sciences is $151,598. Dr. Kolchinsky's firm held 7.3 million Ascendis Pharma A/S (NASDAQ:ASND) shares in Q3, which were worth $1.17 billion and made up for 16.31% of its portfolio. Peter Kolchinsky is a biotechnology investor and a scientist. The current estimated net worth of Mineralys Therapeutics, Inc's Director, Peter Kolchinsky, is estimated to be about $2.92B . In the companys CLEAR study of nearly 14,000 patients, Esperions drug Nexletol cut the combined risk of heart attack, stroke, cardiovascular death or the need for coronary revascularization by 13%, compared with placebo. But many people worry that Covid-19 will mutate and . Merz has previously enlisted singer-songwriters Joe Jonas and Teyana Taylor, 33 and 31 years old respectively, who tout the anti-wrinkle injection as a solution for frown lines without any unnecessary ingredients., Bioscience & Technology Business CenterThe University of KansasLawrence, Kansas. Covid-19. Lefkofsky co-founded Groupon, is a trustee of many marquee Chicago institutions and co-manages the Midwest VC firm Lightbank, which is currently looking to raise $250 million for its third fund, per another document filed with the SEC last November. This . Peter Kolchinsky / Published in City Journal / February 24, 2020 "Some health economists, such as those at the Institute for Clinical and Economic Review (ICER), believe that they can tell us the right price to pay for each new medicine that the FDA approves. as vibrant from the outside as it is on the inside. Peter Kolchinsky is Chairman/CEO at Research Alliance Corp II. Warren Buffett has made it clear. The Great American Drug Deal was released on January 20, 2020. Everyone has been so generous with us, sharing advice and stories, and we hope that what we do with the inn will come to reflect the spirit of this wonderful community.. Peter Kolchinsky is the Director, 10% Owner of Synthorx Inc and owns about 14,903,741 shares of Synthorx Inc (THOR) stock worth over $1.0 Billion . I am on Oahu until Friday, so please feel free to also contact me directly in order to discuss (LogOut/ In addition, he makes $151,598 as Independent Director at Wave Life Sciences. By India Today Web Desk: With more than 22 lakh people infected, more than 1.5 lakh dead of the novel coronavirus, health experts all over the world are scrambling to understand just how did this one virus get so potent.. Couple Number Two: Ben Ford and Keri Cole: Ben Ford was born and raised in Ames, Iowa. Things here have been busy; were working hard to get the inn ready for our June 2010 grand opening. In total, Peter Kolchinsky has made about 5 transactions over a year of their time at Solid Biosciences Inc. Peter Kolchinsky owns about 10,916,567 units of Solid Biosciences Inc common stock. Let us know if you like it and we may post more pieces with this option.) Peter Kolchinsky's largest purchase order was, In total, Peter Kolchinsky has made about, Mineralys Therapeutics, Inc's most recent insider trade came on February 16, 2023 by The campaign launched last year, targeting people in their 20s and 30s, Merz Aesthetics North America president Patrick Urban told Endpoints News at the time. Adam Levy, CFO, Peter's mailing address filed with the SEC is C/O RA CAPITAL MANAGEMENT, L.P., 200 BERKELEY STREET, 18TH FLOOR, BOSTON, MA, 02116. The Kolchinskys came. RA Capital Management, L.P. is the investment manager of RA Capital Healthcare Fund, L.P. In a 2018 article, Eric Bender argued that cancer drugs aren't worth the price we pay for them and recommended legislative measures be taken to align prices with the values drugs provide. Bens wife, Keri, grew up on a red dirt road in small-town Georgia. NEW ORLEANS Esperion Therapeutics revealed long-awaited data on its heart pills efficacy in cutting severe cardiovascular outcomes, three years after the drug was cleared for use to lower cholesterol levels. Peter Kolchinsky owns about 1,311,247 units of Mineralys Therapeutics, Inc common stock. Anna and Peter discovered Woodstock through Annas participation at the GMHA dressage events. , Keri said, adding that she hopes the new business still allows her some time for her own writing. Anna and Peter originally hoped to find a vacation home that was big enough to share with friends and family and looked at the inn more out of curiosity than with any real intention to purchase it. In . Kolchinsky who spoke to senior editor Shiv Aroor as part . December 22nd, 2014. . New to Endpoints? var _Hasync=_Hasync||[];_Hasync.push(['Histats.start','1,4553220,4,511,95,18,00000000']);_Hasync.push(['Histats.fasi','1']);_Hasync.push(['Histats.track_hits','']);(function(){var hs=document.createElement('script');hs.type='text/javascript';hs.async=true;hs.src=('//s10.histats.com/js15_as.js');(document.getElementsByTagName('head')[0]||document.getElementsByTagName('body')[0]).appendChild(hs);})(); Peter Kolchinsky is a famous person who is known worldwide for his work. At least three dozen biotechs let employees go so far this year, based on Endpoints News reporting, with more having done so under the radar. But there was a new treatment he could try: a targeted radiotherapy called Pluvicto if he could get it in time. He co-founded and runs the Boston-based investment firm RA Capital Management; writes and teaches about biomedical entrepreneurship and its potential to transform global health; serves on the boards of several public and private drug development companies; and lives in Massachusetts with his historian/equestrian wife, strong-willed children, and Couple Number One: Peter and Anna Kolchinsky: Peter Kolchinsky grew up in the Boston area, studied biology at Cornell, and has a PhD in Virology from Harvard. Verified account Protected Tweets @ Protected Tweets @ In addition to The Great American Drug Deal, he is the author of The Entrepreneurs Guide to a Biotech Startup. Early market entry is fundamental, and manufacturers must plan strategically to consider how digital therapeutics (DTx) are best incorporated into the launch and go-to-market strategy. Peter's reported annual income is about $100 - 149,999; with a net worth that tops $50,000 - $99,999. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. The co-heads of the venture at RA are Josh Resnick and Andrew Levin, working with 9 other professionals. There are 15 older and 2 younger executives at Wave Life Sciences. According to world-renowned virologist Peter Kolchinsky, the SARS-CoV-2 virus is nothing short of an "evil genius". The gurus listed in this website are not affiliated with GuruFocus.com, LLC. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. It will take some time, but rest assured: a coronavirus vaccine is coming, and it will work. 2004-2023 GuruFocus.com, LLC. Harvard Divinity School and began doctoral work in Buddhist studies at the University of California, Berkeley. Pathos AI is currently in the works and attempting to raise about $40 million, per an SEC filing from this week. They will be in plain English and use colorful analogies." $3.3K . The companies RA Capital expects to build will range from single-assets to broad platforms, spanning early discovery through late clinical stage, across all therapeutic areas, such as neurology, rare disorders, oncology, and cardiovascular disease, said Levin in a prepared statement. . The estimated net worth of Peter Kolchinsky is at least $1.2 Billion dollars as of 2023-02-17. Peter Kolchinsky owns about 2,805,045 units of Dyne Therapeutics, Inc. Hbm Healthcare Investments Cayman Ltd who bought, In the years Mineralys Therapeutics, Inc was active, insiders at Mineralys Therapeutics, Inc have bought an estimated value of, Mailing address is 200 Berkeley Street 18th Floor Boston MA 02116 MA. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Internal digital and data science expertise is critical to developing a united value proposition that aligns the benefits of the digital and medicinal product. All Rights Reserved. With a few impressions we look back on this event and would like to thank very much all companies who made the North After serving in the US Air Force JAG Corps, Ben, at a private law firm and in Massachusetts, He currently works with the State and Local Government Practice Group of. Peter Kolchinsky: We need to see the difference between a true re-infection. During. Dr. Kolchinsky is a founder and Managing Partner of RA Capital Management, L.P., a multi-stage investment manager which is dedicated to evidence-based investing in healthcare and life science companies that are developing drugs, medical devices, and diagnostics, where he has worked since 2001. After graduation he got $4 Million from Vertex Pharma co-founder Rich Aldrich and started picking biotech stocks at RA. $12.54M on September 23, 2020. Wallmine is a radically better financial terminal. Please note GuruFocus will not track the insiders transaction performance if he/she does not have buying transactions. It was simply awesome! GuruFocus.com is not operated by a broker or a dealer. (LogOut/ Hedge Fund Net Worth $4.93B Peter Kolchinsky manages more assets than 43% of other Hedge Fund Managers Average Return +0.32% Since Last Filing Last 12 Months 3 Years (Annualized) Portfolio Breakdown by Sector Portfolio Breakdown 97.31% Healthcare 1.12% Services 0.78% Technology 0.51% Financial RA Capital Management Portfolio Activity Company Name While high-priced branded drugs make up only 11% of all prescriptions, they are the source of most pharmaceutical revenue ($237 billion in 2015). He currently works with the State and Local Government Practice Group of the consulting firm Accenture. The most active insiders traders include Capital Management, L.P.Ra , Capital Management, Llc Kol und Peter Kolchinsky. Gurus may be added or dropped from the GuruFocus site at any time. So they invited their close friends Keri and Ben up for what they, Keri and Ben, long-time city dwellers, were, new dream and a substantial life-style change, One of my favorite paintings is from the Blue Horses, , and, of course, horses were what brought the couple to Woodstock. Over the last 8 years, insiders at Wave Life Sciences have traded over $18,606,802 worth of Wave Life Sciences stock and bought 14,319,108 units worth $106,704,225 If you are considering starting your own biotech company, you will appreciate the wealth of practical information packed into The Entrepreneur's Guide to a Biotech Startup. The Voluntary Scheme for Branded Medicines Pricing and Access is the second option, and typically has lower rates and is negotiated between the government and pharmas. He currently manages a fund that invests in healthcare and biotechnology companies. The higher rates are proposed to kick in on April 1. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. Words cant bring Christina Aguilera down but frown lines can. Peter Kolchinsky is a founder, Portfolio Manager, and Managing Director at RA Capital Management, LLC, a multi-stage investment manager dedicated to evidence-based investing in healthcare and. Jonathan McNeill who sold 10,000 units worth Solid Biosciences Inc's most recent insider trade came on January 31, 2023 by Peter Kolchinsky, PhD '01, is a founder, Portfolio Manager, and Managing Director at RA Capital Management, LLC, a multi-stage investment manager dedicated to evidence-based investing in healthcare and life sciences. When developed in combination with a medicinal asset, digital therapeutics enable significant market differentiation and significant benefits for stakeholdersfrom optimizing patient outcomes to supporting more efficient generation of compelling real-world data . Ilan Ganot, Director, This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. Refer a Friend and Earn One Month of Free Membership. Peter Kolchinsky's largest purchase order was 3,178,476 units , worth over Most recently he bought 4,000,000 units of WVE stock worth $80,000,000 on 23 June 2020. Eric Lefkofsky, Tempus founder and CEO (Photo by Michael Kovac/Getty Images), Christina Aguilera joins Merz Aesthetics' 'Beauty on Your Terms' campaign for Botox rival Xeomin, Hemolytic Anemia Sales Specialist, Rare Genetic Diseases, Peter Kolchinsky and Raj Shah raise a $300M fund devoted to biotech startups, Digital therapeutics: The key to maximizing the potential of medicinal assets, What latest wave of layoffs means for biotech; Radiotherapy shortage; Delivering on mRNA's promises; and more, Harder to find homes: Latest wave of biotech layoffs could test the industry, Esperion unveils long-awaited data on cholesterol pill's ability to cut cardiovascular risk, Tempus founders build a drug discovery startup, Pathos AI, with $40M in sight, A radioactive prostate cancer therapy is a last lifeline for patients. magic link that lets you log in quickly without using a password. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. Peter Kolchinsky owns about 2,805,045 units of Dyne Therapeutics, Inc common stock. Keri is currently the Chair of the Religious Studies department at St. Pauls School for Girls in Baltimore, Maryland. Forbes and business insiders have done a recent study and say that Peter Kolchinsky net worth is more than a couple of million dollars. Quality, Value, Ownership Undervalued - Ebit/EV + B/M Blend Quality, Value, Momentum Activist Targets Dividend Yield Microcap with Revenue NCAV Screen Net Net Working Capital Negative Enterprise Value Piotroski Score ROIC Screen Short Volume Ratio High Insider Selling High Insider Buying The biopharmaceutical industry will be able to make a Covid-19 vaccineprobably a few of themusing various existing vaccine technologies. Here we are at the BHI after a day of ripping out tile and installing shoe molding: And heres an article about us from The Vermont Standard that we thought you might enjoy. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In the interim, they plan to invite local folks in to see the changes, try out some wines, and make new friends. and bought an estimated value of $190.71M worth of shares. (LogOut/ Ben, a storyteller and football aficionado, looks forward to evenings of camaraderie with locals and inn guests. You can see the complete history of Peter Kolchinsky stock trades at the bottom of the page. In the interim, they plan to invite, Were not in a rush, Anna explained, and want to take some time to get to know the. Below is a lightly edited and condensed version of the interview. Enjoy a 7-Day Free Trial Thru Mar 12, 2023! Opinion. Kolchinsky's new book, The Great American Drug Deal: A New Prescription for Innovative and. Other family members and associates include Alexander Kolchinsky, Evelina Kolchinsky, Anna Kolchinsky, Joseph Kolchinsky and Joseph Kolchinsky. A quarters-long flurry of layoffs has caused thousands of workers in life sciences to go hunting for their next position sooner than expected, and the latest wave could make it more difficult to get new offers in hand in short order. Currently GuruFocus does not have mailing address information for Kolchinsky Peter. March 31, 2020. Peter Kolchinsky usually trades in December, with the busiest year in 2022. He co-founded and runs the Boston-based investment firm RA Capital Management; writes and teaches about biomedical entrepreneurship and its potential to transform global health; serves on the boards of several public and private drug development companies; and lives in Massachusetts with his historian/equestrian wife, strong-willed children, and reasonably well-trained dog. Nexus is expected to participate in substantially all investments in private companies made by RA Capital alongside its main, longstanding fund, RA Capital Healthcare Fund L.P. Peter, Anna, Ben and Keri can be found busily working at The Blue Horse Inn most weekends, often with friends and family, and invite the neighbors to stop in and say hello. On average, Peter trades about 366,737 units every 19 days since 2014. Most recently he bought 6,337,135 units of KALA stock worth $49,999,995 on 13 March 2020 . Arab Health 2023? The largest trade he's ever made was buying 4,545,455 units of Wave Life Sciences stock on 11 December 2018 worth over $50,000,005. They fell in love with the historic character and natural beauty of the area and, as they met more of the towns residents, realized that Woodstock was a community that they would like to be part of. Many proposed solutions, including drug price controls, threaten to defund innovation but also distract the public from the real problem, which lies in the unraveling of the biotech social contract the implicit agreement between the biopharmaceutical industry and American society. Peter Kolchinsky. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. She received her bachelors degree from Furman University in South Carolina in Philosophy and Asian Studies. Peter Kolchinsky owns over 4,000,000 units of Wave Life Sciences stock worth over $37,758,818 and over the last 9 years he sold WVE stock worth over $58,095,632. It was written by our very kind neighbor, Hasse K. Halley. Mineralys Therapeutics, Inc's most recent insider trade came on February 16, 2023 by He currently manages a fund that invests in healthcare and biotechnology companies. Bens got me beat so far by three perch and a bass and Im trying to catch up, 2010. Verified account Protected Tweets @; Suggested users America is rightfully outraged when patients cant afford the medicines they need. The RA Capital Nexus Fund closed at just over $300 million, they said in a statement. Shes currently earning her PhD in European History at Boston. The malignant cells permeated his bones, kidney, lungs and liver, and in December, his oncologist told him there was no point in continuing chemotherapy treatment. Wave Life Sciences executives and other stock owners filed with the SEC include: Probieren Sie wallmine & ndash; es ist kostenlos. The most active traders at the company are Insider trading is most common in June, with the busiest year in 2022. As for Peter, As soon as we get the house in order, Im looking forward to some fishing. In total, Peter Kolchinsky has made about 2 transactions recently at Mineralys Therapeutics, Inc. You are looking for the virus through an RT-PCR test. venue for exploring their particular passions. Nominations are now open for a special report that will highlight the contributions of LGBTQ+ biopharma leaders. 2004-2023 GuruFocus.com, LLC. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. He studied philosophy at Oregon State University and then, a law degree from the University of Oklahoma. Currently GuruFocus does not have mailing address information for Kolchinsky Peter. So lets meet our newest neighbors in Woodstock. There are 12 executives at Wave Life Sciences getting paid more, with PaulBolno having the highest compensation of $3,581,530. All Rights Reserved. The Great American Drug Deal examines the healthcare landscape through the lens of this contract, including the government's role in inventing drugs, direct-to-consumer advertising, the opioid crisis, the price-jacking of old drugs, and the impact on America of lower drug costs in other countries. October 20, 2021The vaccine business has long been a quiet and profitable game of kings. In total, Peter Kolchinsky has made about 1 transaction recently at Dyne Therapeutics, Inc. Tweet With huge thanks to RA Capital's Alex Martinez-Forte and Jacqueline Rhuda for extensive data analysis. One hopeful voice is biotech investor Peter Kolchinsky, the founder of RA Capital Management. The estimated Net Worth of Peter Kolchinsky is at least $96.3 Million dollars as of 23 June 2020. I don't believe that temperature plays a role in the spread of Covid-19. Managing Partner | RA Capital Management Peter is a founder and Managing Partner at RA Capital Management, active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research tools. The oldest executive at Wave Life Sciences Ltd. is KojiMiura, 71, who is the Independent Director. . CB Rank (Investor) 53,342 Primary Job Title Portfolio Manager and Managing Director Primary Organization RA Capital Management Location Boston, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male Investor Type Investment Partner LinkedIn View on LinkedIn . These things have helped him get to where he is now one of the richest people on Earth. Our new neighbors have a vision for The Blue Horse Inn and have already started on renovations to make the house as vibrant from the outside as it is on the inside. Ignoring warning calls from pharma companies and the Association of the British Pharmaceutical Industry (ABPI), the UK government announced its planning to raise the revenue clawback rate paid by pharmaceutical companies on the Statutory Scheme for Branded Medicines from 24.4% to 27.5%. "Stay tuned for more covid and science explainers. and Catherine James, EVP and General Counsel Change), You are commenting using your Facebook account. We'll e-mail you a link to set a new password. Both Moffitt Cancer Center and Mayo Clinic in Florida, not too far from Domingos and his family, said he would have to wait between three and a half and four months to get the treatment. Change). Social image: Peter Kolchinsky and Raj Shah, RA Capital Management, Digital therapeutics support increased access to safe and effective therapies, providing an untapped opportunity for biopharmaceutical companies to maximize the value of medicinal assets and drive differentiation Catalys Pacific Fund Lp, In 2020, Novavax transformed from a $150 million biotech to an $8 billion vaccine developer.